Cargando…
Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
The ability of protein–protein interactions to regulate cellular processes in both beneficial and detrimental ways has made them obvious drug targets. The Bcl‐2 family of proteins undergo a series of protein–protein interactions which regulate the intrinsic cell‐death pathway. The pro‐survival membe...
Autores principales: | Beekman, Andrew M., Howell, Lesley A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991272/ https://www.ncbi.nlm.nih.gov/pubmed/26696548 http://dx.doi.org/10.1002/cmdc.201500497 |
Ejemplares similares
-
Identification of Small‐Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia‐1 (Mcl‐1)
por: Beekman, Andrew M., et al.
Publicado: (2015) -
Peptide‐Directed Binding for the Discovery of Modulators of α‐Helix‐Mediated Protein–Protein Interactions: Proof‐of‐Concept Studies with the Apoptosis Regulator Mcl‐1
por: Beekman, Andrew Michael, et al.
Publicado: (2017) -
Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
por: Holderfield, M, et al.
Publicado: (2014) -
Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance
por: Kovacikova, Kristina, et al.
Publicado: (2020) -
Developing Small‐Molecule Inhibitors of HECT‐Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities
por: Chen, Dan, et al.
Publicado: (2018)